The canine fungal infection treatment market is projected to grow from USD 1,056.4 million in 2026 to USD 2,238.8 million by 2036, at a CAGR of 7.8%. Azole antifungals will dominate with a 42.0% market share, while dermatophytosis will lead the applications segment with a 58.0% share.